Yi Zhou
Direktor/Vorstandsmitglied bei AKESO, INC.
Profil
Dr. Yi Zhou is on the Board of Directors at OrbusNeich Medical Group Holdings Ltd., Akeso, Inc., Aoran Biotechnology (Shanghai) Co. Ltd.
and Genfleet Therapeutics (Shanghai), Inc. Dr. Zhou also served on the board at Shenzhen YHLO Biotech Co., Ltd.
He received his undergraduate degree from Hengyang Normal University, a graduate degree from Hunan Normal University and a doctorate degree from Peking University.
Aktive Positionen von Yi Zhou
| Unternehmen | Position | Beginn |
|---|---|---|
| AKESO, INC. | Direktor/Vorstandsmitglied | 01.11.2019 |
| ORBUSNEICH MEDICAL GROUP HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 28.09.2021 |
Aoran Biotechnology (Shanghai) Co. Ltd.
 Aoran Biotechnology (Shanghai) Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Aoran Biotechnology (Shanghai) Co. Ltd. is a biotechnology company based in Shanghai, China. Aoran Biotechnology specializes in molecular diagnostics. The Chinese company was founded in 2015 and the CEO is Chang Yu Jia. | Direktor/Vorstandsmitglied | - |
Genfleet Therapeutics (Shanghai), Inc.
 Genfleet Therapeutics (Shanghai), Inc. Miscellaneous Commercial ServicesCommercial Services Genfleet Therapeutics (Shanghai), Inc. is a Chinese clinical-stage biotechnology company that focuses on developing novel drug candidates for unmet medical needs in oncology and immunology. The company is based in Shanghai, China, and was founded in 2017 by Jiong Lan and Qiang Lü. The company has built up industry-leading capabilities and expertise in developing both small molecules and biologics since its inception in 2017. Genfleet's proprietary and fully integrated R&D platform highlights multiple cutting-edge products with novel mechanisms and IP. The company's pipeline includes over 10 programs, many of which have entered multi-regional clinical trials across China. Genfleet has completed co-development partnerships with a number of publicly listed companies worldwide. Jiong Lan has been the CEO since 2017. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Yi Zhou
| Unternehmen | Position | Ende |
|---|---|---|
| SHENZHEN YHLO BIOTECH CO., LTD. | Direktor/Vorstandsmitglied | - |
Ausbildung von Yi Zhou
| Peking University | Doctorate Degree |
| Hunan Normal University | Graduate Degree |
| Hengyang Normal University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SHENZHEN YHLO BIOTECH CO., LTD. | Health Technology |
| AKESO, INC. | Health Technology |
| ORBUSNEICH MEDICAL GROUP HOLDINGS LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Genfleet Therapeutics (Shanghai), Inc.
Genfleet Therapeutics (Shanghai), Inc. Miscellaneous Commercial ServicesCommercial Services Genfleet Therapeutics (Shanghai), Inc. is a Chinese clinical-stage biotechnology company that focuses on developing novel drug candidates for unmet medical needs in oncology and immunology. The company is based in Shanghai, China, and was founded in 2017 by Jiong Lan and Qiang Lü. The company has built up industry-leading capabilities and expertise in developing both small molecules and biologics since its inception in 2017. Genfleet's proprietary and fully integrated R&D platform highlights multiple cutting-edge products with novel mechanisms and IP. The company's pipeline includes over 10 programs, many of which have entered multi-regional clinical trials across China. Genfleet has completed co-development partnerships with a number of publicly listed companies worldwide. Jiong Lan has been the CEO since 2017. | Commercial Services |
Aoran Biotechnology (Shanghai) Co. Ltd.
Aoran Biotechnology (Shanghai) Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Aoran Biotechnology (Shanghai) Co. Ltd. is a biotechnology company based in Shanghai, China. Aoran Biotechnology specializes in molecular diagnostics. The Chinese company was founded in 2015 and the CEO is Chang Yu Jia. | Commercial Services |
